Zinc metabolism and its role in immunity status in subjects with trisomy 21: chromosomal dosage effect
- PMID: 38694501
- PMCID: PMC11061464
- DOI: 10.3389/fimmu.2024.1362501
Zinc metabolism and its role in immunity status in subjects with trisomy 21: chromosomal dosage effect
Abstract
Introduction: Trisomy 21 (T21), which causes Down syndrome (DS), is the most common chromosomal aneuploidy in humankind and includes different clinical comorbidities, among which the alteration of the immune system has a heavy impact on patient's lives. A molecule with an important role in immune response is zinc and it is known that its concentration is significantly lower in children with T21. Different hypotheses were made about this metabolic alteration and one of the reasons might be the overexpression of superoxide dismutase 1 (SOD1) gene, as zinc is part of the SOD1 active enzymatic center.
Methods: The aim of our work is to explore if there is a linear correlation between zinc level and immune cell levels measured in a total of 217 blood samples from subjects with T21. Furthermore, transcriptome map analyses were performed using Transcriptome Mapper (TRAM) software to investigate whether a difference in gene expression is detectable between subjects with T21 and euploid control group in tissues and cells involved in the immune response such as lymphoblastoid cells, thymus and white blood cells.
Results: Our results have confirmed the literature data stating that the blood zinc level in subjects with T21 is lower compared to the general population; in addition, we report that the T21/control zinc concentration ratio is 2:3, consistent with a chromosomal dosage effect due to the presence of three copies of chromosome 21. The transcriptome map analyses showed an alteration of some gene's expression which might explain low levels of zinc in the blood.
Discussion: Our data suggest that zinc level is not associated with the levels of immunity cells or proteins analyzed themselves and rather the main role of this ion might be played in altering immune cell function.
Keywords: down syndrome; immunity disorder; integration; transcriptome; zinc.
Copyright © 2024 Ramacieri, Locatelli, Semprini, Pelleri, Caracausi, Piovesan, Cicilloni, Vigna, Vitale, Sperti, Corvaglia, Pirazzoli, Strippoli, Catapano, Vione and Antonaros.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
The transcriptome profile of human trisomy 21 blood cells.Hum Genomics. 2021 May 1;15(1):25. doi: 10.1186/s40246-021-00325-4. Hum Genomics. 2021. PMID: 33933170 Free PMC article.
-
Increased endothelial sclerostin caused by elevated DSCAM mediates multiple trisomy 21 phenotypes.J Clin Invest. 2024 Jun 3;134(11):e167811. doi: 10.1172/JCI167811. J Clin Invest. 2024. PMID: 38828726 Free PMC article.
-
Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation.Sci Rep. 2017 Nov 1;7(1):14818. doi: 10.1038/s41598-017-13858-3. Sci Rep. 2017. PMID: 29093484 Free PMC article.
-
[Trisomy 21 and breast cancer: A genetic abnormality which protects against breast cancer?].Gynecol Obstet Fertil. 2016 Apr;44(4):211-7. doi: 10.1016/j.gyobfe.2016.02.016. Epub 2016 Mar 28. Gynecol Obstet Fertil. 2016. PMID: 27032759 Review. French.
-
Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.APMIS Suppl. 1993;40:71-9. APMIS Suppl. 1993. PMID: 8311993 Review.
References
-
- Lejeune J, Turpin R, Gautier M. [Mongolism; a chromosomal disease (trisomy)]. Bull Acad Natl Med. (1959) 143:256–65. - PubMed
-
- Illouz T, Biragyn A, Iulita MF, Flores-Aguilar L, Dierssen M, De Toma I, et al. . Immune dysregulation and the increased risk of complications and mortality following respiratory tract infections in adults with down syndrome. Front Immunol. (2021) 12:621440. doi: 10.3389/fimmu.2021.621440 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous